Literature DB >> 21990095

Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study.

Colleen M Costelloe1, Vikas Kundra, Jingfei Ma, Beth A Chasen, Eric M Rohren, Roland L Bassett, John E Madewell.   

Abstract

PURPOSE: To evaluate the feasibility of fast Dixon whole-body (WB) magnetic resonance imaging (MRI) for detecting bone and liver metastasis in clinical patients and to compare its performance with skeletal scintigraphy (SS) for detecting bone metastases using reference imaging with >1 year follow-up as the gold standard.
MATERIALS AND METHODS: Twenty-nine patients with bone metastases prospectively underwent WB MRI and SS. WB MRI included coronal T2, axial T1 with and without intravenous gadolinium (including triphasic liver sequences), and axial diffusion-weighted imaging, plus spinal sagittal postcontrast T1-weighted images. The skeleton was divided into 16 segments. Reviewers blinded to other images identified up to five lesions per segment and rated them using a five-point confidence scale for metastatic disease. Sensitivities and specificities were compared using the McNemar test.
RESULTS: The sensitivity of WB MRI and SS in detecting bone metastases was 70.8% and 59.6% (P = 0.003), respectively; specificity was 89.1% and 98.7% (P < 0.0001). WB MRI detected all livers with metastases (n = 8). One focal nodular hyperplasia was classified as a metastasis on WB MRI.
CONCLUSION: Fast Dixon WB MRI is feasible in clinical patients, highly specific, and more sensitive than SS in detecting bone metastases, and can detect metastases of the liver.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990095      PMCID: PMC3265627          DOI: 10.1002/jmri.22815

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  25 in total

1.  Dual-echo Dixon imaging with flexible choice of echo times.

Authors:  Holger Eggers; Bernhard Brendel; Adri Duijndam; Gwenael Herigault
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

2.  Two-point dixon method with flexible echo times.

Authors:  Johan Berglund; Håkan Ahlström; Lars Johansson; Joel Kullberg
Journal:  Magn Reson Med       Date:  2010-11-16       Impact factor: 4.668

3.  Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.

Authors:  Gerwin P Schmidt; Stefan O Schoenberg; Rupert Schmid; Robert Stahl; Reinhold Tiling; Christoph R Becker; Maximilian F Reiser; Andrea Baur-Melnyk
Journal:  Eur Radiol       Date:  2006-09-02       Impact factor: 5.315

4.  Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI.

Authors:  Jingfei Ma; Anthony T Vu; Jong Bum Son; Haesun Choi; John D Hazle
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

5.  Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

Authors:  R Venkitaraman; G J R Cook; D P Dearnaley; C C Parker; V Khoo; R Eeles; R A Huddart; A Horwich; S A Sohaib
Journal:  J Med Imaging Radiat Oncol       Date:  2009-06       Impact factor: 1.735

6.  Fast dixon-based multisequence and multiplanar MRI for whole-body detection of cancer metastases.

Authors:  Jingfei Ma; Colleen M Costelloe; John E Madewell; Gabriel N Hortobagyi; Marjorie C Green; Guang Cao; Fei Sun; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

7.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Yumiko Onishi; Daisuke Takenaka; Munenobu Nogami; Takeshi Yoshikawa; Sumiaki Matsumoto; Yoshikazu Kotani; Kazuro Sugimura
Journal:  Radiology       Date:  2008-06-06       Impact factor: 11.105

8.  Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.

Authors:  Katsuyuki Nakanishi; Midori Kobayashi; Kazunori Nakaguchi; Miyaji Kyakuno; Nobuyuki Hashimoto; Hiromitsu Onishi; Noboru Maeda; Saki Nakata; Masatomo Kuwabara; Takamichi Murakami; Hironobu Nakamura
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

9.  Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.

Authors:  S A Sohaib; G Cook; S D Allen; M Hughes; T Eisen; M Gore
Journal:  Br J Radiol       Date:  2009-02-16       Impact factor: 3.039

Review 10.  Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.

Authors:  Colleen M Costelloe; Eric M Rohren; John E Madewell; Tsuyoshi Hamaoka; Richard L Theriault; Tse-Kuan Yu; Valerae O Lewis; Jingfei Ma; R Jason Stafford; Ana M Tari; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Lancet Oncol       Date:  2009-06       Impact factor: 41.316

View more
  12 in total

Review 1.  The Dixon technique for MRI of the bone marrow.

Authors:  Niels van Vucht; Rodney Santiago; Bianca Lottmann; Ian Pressney; Dorothee Harder; Adnan Sheikh; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2019-07-15       Impact factor: 2.199

2.  Fat saturation in dynamic breast MRI at 3 Tesla: is the Dixon technique superior to spectral fat saturation? A visual grading characteristics study.

Authors:  P Clauser; K Pinker; T H Helbich; P Kapetas; M Bernathova; P A T Baltzer
Journal:  Eur Radiol       Date:  2014-05-04       Impact factor: 5.315

3.  Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology.

Authors:  Timothy Jp Bray; Manil D Chouhan; Shonit Punwani; Alan Bainbridge; Margaret A Hall-Craggs
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

4.  Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence.

Authors:  Colleen M Costelloe; John E Madewell; Vikas Kundra; Robyn K Harrell; Roland L Bassett; Jingfei Ma
Journal:  Magn Reson Imaging       Date:  2013-01-03       Impact factor: 2.546

5.  Detection of vertebral metastases: a comparison between the modified Dixon turbo spin echo T2 weighted MRI and conventional T1 weighted MRI: a preliminary study in a tertiary centre.

Authors:  Seok Hahn; Young Han Lee; Jin-Suck Suh
Journal:  Br J Radiol       Date:  2018-03-15       Impact factor: 3.039

Review 6.  Simultaneous PET-MRI in oncology: a solution looking for a problem?

Authors:  Thomas E Yankeelov; Todd E Peterson; Richard G Abramson; David Izquierdo-Garcia; David Garcia-Izquierdo; Lori R Arlinghaus; Xia Li; Nkiruka C Atuegwu; Ciprian Catana; H Charles Manning; Zahi A Fayad; John C Gore
Journal:  Magn Reson Imaging       Date:  2012-07-15       Impact factor: 2.546

7.  Non-contrast-enhanced whole-body magnetic resonance imaging in the general population: the incidence of abnormal findings in patients 50 years old and younger compared to older subjects.

Authors:  Andrzej Cieszanowski; Edyta Maj; Piotr Kulisiewicz; Ireneusz P Grudzinski; Karolina Jakoniuk-Glodala; Irena Chlipala-Nitek; Bartosz Kaczynski; Olgierd Rowinski
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

Review 8.  Whole-body MRI in pediatric patients with cancer.

Authors:  Marcos Duarte Guimarães; Julia Noschang; Sara Reis Teixeira; Marcel Koenigkam Santos; Henrique Manoel Lederman; Vivian Tostes; Vikas Kundra; Alex Dias Oliveira; Bruno Hochhegger; Edson Marchiori
Journal:  Cancer Imaging       Date:  2017-02-10       Impact factor: 3.909

Review 9.  Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review.

Authors:  Alessandro Stecco; Alessandra Trisoglio; Eleonora Soligo; Sara Berardo; Lidiia Sukhovei; Alessandro Carriero
Journal:  Diagnostics (Basel)       Date:  2018-07-09

Review 10.  Diagnostic Performance of Diffusion-weighted Magnetic Resonance Imaging in Bone Malignancy: Evidence From a Meta-Analysis.

Authors:  Li-Peng Liu; Long-Biao Cui; Xin-Xin Zhang; Jing Cao; Ning Chang; Xing Tang; Shun Qi; Xiao-Liang Zhang; Hong Yin; Jian Zhang
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.